P. M. T. Tien, P. N. Hiep, P. C. Duy, N. T. Ai, P. T. D. Quyen, and N. T. D. My, “Evaluate the effectiveness of tyrosine kinase inhibitors as first-line treatment for advanced non-small cell lung cancer (NSCLC) with mutated EGFR”, JCMHCH, vol. 10, no. 50, pp. 62–69, Aug. 2018.